Choosing a disease modifying drug: Maria’s story
Maria was diagnosed with relapsing remitting MS last June. Here she shares her experience of choosing a disease modifying drug. "It’s scary being asked to make such a massive decision, so if you do feel afraid, that’s normal," Maria tells us.
Choosing a disease modifying drug: Laurens's story
What do you do when the disease modifying drug (DMD) you've chosen isn't working? In this guest blog, Lauren shares her thoughts around choosing an MS treatment and what it is like having to change to a new one.
Choosing a disease modifying drug: Toni's Story
Choosing a disease modifying drug (DMD) is an individual decision and it can be important to weigh up your options and think about what might work best for you. In this guest blog, Toni shares her experiences of choosing an MS treatment and explains what it was like to start on Plegridy.
Choosing a disease modifying drug: Jane's Story
Choosing which disease modifying drug (DMD) to start is not always easy and sometimes you'll find that you don't get on with the drug you have chosen. In this guest blog, Jane shares her experience of making a decision about treatment.
Can’t change what happens, just have to deal with it - Wayne's Story
When Wayne first started experiencing tingling and weakness in his hand and wrist, he ignored it "like a typical bloke". But then six months later, in May this year, he was diagnosed with relapsing remitting MS. Here he tells us about coming to terms with the diagnosis, starting treatment, and why he's determined to "keep smiling".
A new beginning? A personal perspective on having to switch treatment.
Leigh was diagnosed with rapidly-evolving relapsing-remitting multiple sclerosis in 2013. In this guest blog she tells us what it was like finding out that you have to stop one disease modifying drug and move on to another option
MS Decisions: Getting the balance right
Neurologist Dr Paul Molyneux and MS specialist nurse Ruth Stross both sat on the editorial panel for MS Decisions. Here they explain why they got involved and how they believe it will help them help people with MS.
MS Decisions: Clear, impartial and easy to use
Anna is 29 and was diagnosed with relapsing remitting MS in 2012. She has been taking Avonex, but is now reconsidering her options. She volunteered to test drive the new MS Decisions and was very impressed.
MS Decisions: Getting involved
Karen McTaggart and David Harrison were both diagnosed with MS in 2014, and volunteered to help us review MS Decisions. Here they tell us why they got involved and how they helped.
Introducing MS Decisions
We’ve worked closely with people with MS, MS nurses and neurologists to develop the new MS Decisions. The site now features a guide to making your decision, full details about all of the drugs, a list of common questions, as well the decision aid.